[AEYE Health in The Times of Israel] Seeing straight with the help of artificial intelligence
Israeli startup AEYE aims to save the sight of millions by making retinal exams cost-effective and readily available Read more...
Read MoreMar 2, 2022 | News Center, Newsticker
Israeli startup AEYE aims to save the sight of millions by making retinal exams cost-effective and readily available Read more...
Read MoreFeb 11, 2022 | News Center
Digital health company AEYE Health was founded on the desire to provide fully automated, artificial intelligence (AI) based diagnostic screening tools for retinal imaging. According to the Ophthalmology Times, the company has more recently finished a clinical trial evaluating one of its AI tools for the detection of mild-to-moderate diabetic retinopathy. Read more...
Read MoreFeb 7, 2022 | News Center, Newsticker
AEYE Health is reporting results from its pivotal FDA-clinical trial for the autonomous detection of more-than-mild diabetic retinopathy. Read more...
Read MoreMar 30, 2021 | News Center
AEYE Health and UMass Medical School, in collaboration with UMass Memorial Health Care, are developing a system which enables family doctors to screen patients for various retinal conditions and enable timely referrals to specialists. Read more...
Read MoreOct 9, 2020 | News Center
Zack Dvey-Aharon, Ph.D., is the CEO and Co-Founder of AEYE Health, a company with a mission to prevent world blindness. With AEYE Health’s automated diagnostic system, retinal screening becomes accessible practically anywhere. Read more...
Read More